International hemodialysis patient outcomes comparisons revisited: The role of practice patterns and other factors

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue SUPPL. 1, 2009, Pages

  Robinson, Bruce M ^a   Port, Friedrich K ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONFERENCE PAPER; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; PATIENT CARE; POPULATION RESEARCH; REGISTER; SURVIVAL; TREATMENT RESPONSE; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EUROPE; HEALTHCARE DISPARITIES; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RENAL DIALYSIS; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 73849108914     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04720709     Document Type: Conference Paper

References (20)

1. Held PJ, Brunner F, Odaka M, Garcia J, Port FK, Gaylin DS: Five-year survival for end stage renal disease patients in the US, Europe, and Japan 1982-87. Am J Kidney Dis 15: 451-457, 1990
2. Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, Maroni BL, Wolfe RA, Held PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int 57[Suppl 74]: S74-S81, 2000
3. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner M, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. Am J Kidney Dis 44[Suppl 2]: S7-S15, 2004
4. Goodkin DA, Mapes DL, Held PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): How can we improve the care of hemodialysis patients? Semin Dial 14: 157-159, 2001
5. Robinson BM, Port FK: The Dialysis Outcomes and Practice Patterns Study (DOPPS): Reviewing the first 12 years and looking ahead [Editorial]. NephSAP 7: 367-373, 2008
6. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003
7. US Renal Data System: USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
8. Wolfe RA, Ashby VB, Port FK, Hulbert-Shearon TE, Loos ME, Daugirdas JT, Jones CA, Levine NW: The association between regional death rates and standardized mortality ratios (SMR) by health service areas (HSA) and race and sex group [Abstract]. J Am Soc Nephrol 9: 230A,1998
9. Yoshino M, Kuhlmann MK, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC, Kotanko P, Kramar R, Nakao T, Nandakumar M, Ramirez S, van der Sande FM, Schön S, Simpson K, Walker RG, Zaluska W, Levin NW: International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17: 3510-3519, 2006
10. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands J, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis. Am J Kidney Dis 53: 475-491, 2009
11. Foley RN, Hakim RM: Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol 20: 1432-1435, 2009
12. Port FK, Orzol SM, Held PJ, Wolfe RA: Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 32[Suppl 4]: S34-S38, 1998
13. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphate, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52: 519-530, 2008
14. Evidence for improving patient care and outcomes: the Dialysis Outcomes and Practice Patterns Study (DOPPS) and Kidney Disease Outcomes Quality Initiative (K/DOQI). Am J Kidney Dis 44[Suppl 2]: S1-S68, 2004
15. Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, Jacobson SH, Robinson BM, Port FK, Mason NA, Young EW: Prescription of antihypertensive agents to haemodialysis patients: Time trends and associations with patient characteristics, country and survival in the DOPPS. Nephrol Dial Transplant May 14, 2009 [epub ahead of print]
16. Newhouse JP, McClellan M: Econometrics in outcomes research: The use of instrumental variables. Annu Rev Public-Health 19: 17-34, 1998
17. Angrist J, Imbens G, Rubin D: Identification of causal effects using instrumental variables. J Am Stat Assoc 91: 444-455, 1996
18. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S: Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 17: 268-275, 2006
19. Saran R, Bragg-Gresham JL, Wizemann V, Twardowski Z, Saito A, Levin NW, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
20. Tentori F, Bragg-Gresham JL, Gillespie BW, Pisoni RL, Port FK, Robinson B, Depner T, Ethier J, Vanholder R, Fukuhara S, Saran R: The practice of prescribing longer hemodialysis (HD) sessions improves patient outcomes: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) [Abstract]. Nephrol Dial Transplant Plus 2[Suppl 2]: abstract [M428], 2009